Avraham Pharmaceuticals Ltd.

Industry executives and biopharmaceutical analysts are reluctant to say that the failure of Eli Lilly & Co. ’s solanezumab in a third Phase III clinical trial is the end of the road for the amyloid

IN VITRO DIAGNOSTICS Adarza Biosystems Inc. Adarza Biosystems Inc. raises $5mm in Series B round Adarza Biosystems Inc. raised $5mm in its Series B financing round led by Cultivation Capital,

In Vitro Diagnostics Biocartis SA Series C generates €71mm for Biocartis Four-year-old Swiss molecular diagnostics company Biocartis NV has raised €71mm ($96mm) in its Series C financing led by

In Vitro Diagnostics AltheaDx Inc. AltheaDx brings in $6mm from Series A financing March —Telegraph Hill Partners has led a group of three other investors which participated in the $6mm Series A fina